COMPANY INSIGHT

Sponsored by TSS

TSS

The life science industry faces many new challenges moving forward. The need to save costs, meet regulations and implement sustainability initiatives has never been greater. Transforming your supply chain with our cloud temperature management solution can help you meet these challenges and achieve measurable ROI. It delivers big data-driven analytics, and documents end-to-end visibility of drugs as they move through the supply chain. This ensure compliance with regulators’ monitoring requirements, while minimizing administrative paperwork

Transform End-to-End drug delivery with powerful Analytics and Insights

With Pharma for pharma

TSS Cloud temperature management solution, which comes with 20-years of drug distribution data and best practices, has been developed with some of the world’s leading pharmaceutical companies. They use it on a daily basis to guarantee drugs are delivered safely to patients, improve the performance of service providers, streamline the delivery process, and identify and implement sustainability initiatives. For many of them it has become a key component of their risk-based approach to managing the supply chain.

Powerful analytics

The secure software is tracker-independent. It can be incorporated into an existing ERP system or run separately on any computer or device. It can be tailored to meet the requirements of your operation – no matter where you are in the product life cycle – to gain key insights that drive competitive advantage. You can compare everything from shipment routes and modes of transport to freight forwarder performance, and the impact different packaging has on a drug.

Always at Your Service

TSS intuitive analytics tools capture and secure big data and present it in easy to read dashboards to manage and transform your supply chain. Our expert team can provide the support you need to interpret data and identify initiatives to reduce unnecessary costs in your drug delivery process. They have experience from working with millions of successful missions, for 20,000 users in 100 plus countries. Together with our clients all around the world they help manufactures identify millions of dollars in annual savings and help clinical trial companies minimize over production of drugs, among many other valuable things.

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI